Answer
Yes. It is licensed for bleeding and peri-procedural haemostasis in congenital factor VII deficiency.
Sources for this answer
- NovoSeven 2mg (100 KIU) powder and solvent for solution for injection — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.